Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling

Chae Ryun Lee, Jung Nyeo Chun, Sang Yeob Kim, Soonbum Park, Su Hwa Kim, Eun Jung Park, In-San Kim, Nam Hyuk Cho, In Gyu Kim, Insuk So, Tae Woo Kim, Ju Hong Jeon

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Cyclosporin A (CsA) has antitumor effects on various cancers including prostate cancer. However, its antitumor mechanism is poorly understood. In this study, we showed that AMP-activated protein kinase (AMPK) mediates the antitumor effect of CsA on prostate cancer cells. CsA attenuated cell growth by inducing a G1 arrest through the inhibition of mTOR complex 1 (mTORC1) signaling. In this context, Akt was paradoxically activated downstream of the EGF receptor (EGFR)-mediated increase in phosphatidylinositol 3,4,5-trisphosphate (PIP 3) production. However, CsA also caused a Ca 2+/calmodulin- dependent protein kinase kinase β (CaMKKβ)-dependent activation of AMPK, which inhibits mTORC1 signaling; this led to ineffective Akt signaling. An EGFR or Akt inhibitor increased the growth suppressive activity of CsA, whereas the combination of an AMPK inhibitor and CsA markedly rescued cells from the G1 arrest and increased cell growth. These results provide novel insights into the molecular mechanisms of CsA on cancer signaling pathways.

Original languageEnglish
Pages (from-to)425-431
Number of pages7
JournalBiochemical Pharmacology
Volume84
Issue number4
DOIs
Publication statusPublished - 2012 Aug 15

Fingerprint

Calcium-Calmodulin-Dependent Protein Kinases
Cell growth
Cyclosporine
Prostatic Neoplasms
AMP-Activated Protein Kinases
Growth
Epidermal Growth Factor Receptor
Growth Inhibitors
Protein Kinase Inhibitors
AMP-activated protein kinase kinase
Phosphotransferases
Chemical activation
Cells

Keywords

  • Akt
  • AMPK
  • Cyclosporin A
  • mTOR
  • Prostate cancer

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry

Cite this

Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling. / Lee, Chae Ryun; Chun, Jung Nyeo; Kim, Sang Yeob; Park, Soonbum; Kim, Su Hwa; Park, Eun Jung; Kim, In-San; Cho, Nam Hyuk; Kim, In Gyu; So, Insuk; Kim, Tae Woo; Jeon, Ju Hong.

In: Biochemical Pharmacology, Vol. 84, No. 4, 15.08.2012, p. 425-431.

Research output: Contribution to journalArticle

Lee, CR, Chun, JN, Kim, SY, Park, S, Kim, SH, Park, EJ, Kim, I-S, Cho, NH, Kim, IG, So, I, Kim, TW & Jeon, JH 2012, 'Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling', Biochemical Pharmacology, vol. 84, no. 4, pp. 425-431. https://doi.org/10.1016/j.bcp.2012.05.009
Lee, Chae Ryun ; Chun, Jung Nyeo ; Kim, Sang Yeob ; Park, Soonbum ; Kim, Su Hwa ; Park, Eun Jung ; Kim, In-San ; Cho, Nam Hyuk ; Kim, In Gyu ; So, Insuk ; Kim, Tae Woo ; Jeon, Ju Hong. / Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling. In: Biochemical Pharmacology. 2012 ; Vol. 84, No. 4. pp. 425-431.
@article{9828f5849c864c71b91369fbd6f194b2,
title = "Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling",
abstract = "Cyclosporin A (CsA) has antitumor effects on various cancers including prostate cancer. However, its antitumor mechanism is poorly understood. In this study, we showed that AMP-activated protein kinase (AMPK) mediates the antitumor effect of CsA on prostate cancer cells. CsA attenuated cell growth by inducing a G1 arrest through the inhibition of mTOR complex 1 (mTORC1) signaling. In this context, Akt was paradoxically activated downstream of the EGF receptor (EGFR)-mediated increase in phosphatidylinositol 3,4,5-trisphosphate (PIP 3) production. However, CsA also caused a Ca 2+/calmodulin- dependent protein kinase kinase β (CaMKKβ)-dependent activation of AMPK, which inhibits mTORC1 signaling; this led to ineffective Akt signaling. An EGFR or Akt inhibitor increased the growth suppressive activity of CsA, whereas the combination of an AMPK inhibitor and CsA markedly rescued cells from the G1 arrest and increased cell growth. These results provide novel insights into the molecular mechanisms of CsA on cancer signaling pathways.",
keywords = "Akt, AMPK, Cyclosporin A, mTOR, Prostate cancer",
author = "Lee, {Chae Ryun} and Chun, {Jung Nyeo} and Kim, {Sang Yeob} and Soonbum Park and Kim, {Su Hwa} and Park, {Eun Jung} and In-San Kim and Cho, {Nam Hyuk} and Kim, {In Gyu} and Insuk So and Kim, {Tae Woo} and Jeon, {Ju Hong}",
year = "2012",
month = "8",
day = "15",
doi = "10.1016/j.bcp.2012.05.009",
language = "English",
volume = "84",
pages = "425--431",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Cyclosporin A suppresses prostate cancer cell growth through CaMKKβ/AMPK-mediated inhibition of mTORC1 signaling

AU - Lee, Chae Ryun

AU - Chun, Jung Nyeo

AU - Kim, Sang Yeob

AU - Park, Soonbum

AU - Kim, Su Hwa

AU - Park, Eun Jung

AU - Kim, In-San

AU - Cho, Nam Hyuk

AU - Kim, In Gyu

AU - So, Insuk

AU - Kim, Tae Woo

AU - Jeon, Ju Hong

PY - 2012/8/15

Y1 - 2012/8/15

N2 - Cyclosporin A (CsA) has antitumor effects on various cancers including prostate cancer. However, its antitumor mechanism is poorly understood. In this study, we showed that AMP-activated protein kinase (AMPK) mediates the antitumor effect of CsA on prostate cancer cells. CsA attenuated cell growth by inducing a G1 arrest through the inhibition of mTOR complex 1 (mTORC1) signaling. In this context, Akt was paradoxically activated downstream of the EGF receptor (EGFR)-mediated increase in phosphatidylinositol 3,4,5-trisphosphate (PIP 3) production. However, CsA also caused a Ca 2+/calmodulin- dependent protein kinase kinase β (CaMKKβ)-dependent activation of AMPK, which inhibits mTORC1 signaling; this led to ineffective Akt signaling. An EGFR or Akt inhibitor increased the growth suppressive activity of CsA, whereas the combination of an AMPK inhibitor and CsA markedly rescued cells from the G1 arrest and increased cell growth. These results provide novel insights into the molecular mechanisms of CsA on cancer signaling pathways.

AB - Cyclosporin A (CsA) has antitumor effects on various cancers including prostate cancer. However, its antitumor mechanism is poorly understood. In this study, we showed that AMP-activated protein kinase (AMPK) mediates the antitumor effect of CsA on prostate cancer cells. CsA attenuated cell growth by inducing a G1 arrest through the inhibition of mTOR complex 1 (mTORC1) signaling. In this context, Akt was paradoxically activated downstream of the EGF receptor (EGFR)-mediated increase in phosphatidylinositol 3,4,5-trisphosphate (PIP 3) production. However, CsA also caused a Ca 2+/calmodulin- dependent protein kinase kinase β (CaMKKβ)-dependent activation of AMPK, which inhibits mTORC1 signaling; this led to ineffective Akt signaling. An EGFR or Akt inhibitor increased the growth suppressive activity of CsA, whereas the combination of an AMPK inhibitor and CsA markedly rescued cells from the G1 arrest and increased cell growth. These results provide novel insights into the molecular mechanisms of CsA on cancer signaling pathways.

KW - Akt

KW - AMPK

KW - Cyclosporin A

KW - mTOR

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84864120335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864120335&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2012.05.009

DO - 10.1016/j.bcp.2012.05.009

M3 - Article

VL - 84

SP - 425

EP - 431

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 4

ER -